期刊文献+

甲型H1N1流感病毒亚单位疫苗对小鼠的免疫原性观察 被引量:1

To evaluate the immunogenicity of H1N1 influenza subunit vaccine in mice
下载PDF
导出
摘要 目的:观察国产甲型H1N1流感病毒亚单位疫苗对小鼠的免疫原性。方法:将不同血凝素含量(20、30、40μg/ml)各3批甲型H1N1流感病毒亚单位疫苗分别免疫小鼠,腹腔注射0.5 ml/只,每批疫苗又分为1针组、2针组,每组10只,2针间隔1周,同时设对照组。首针免疫后21天,分别采血,分离血清,检测血凝抑制抗体效价和中和抗体效价,观察疫苗的免疫原性。结果:血凝素含量为20μg/ml的甲型H1N1流感病毒亚单位疫苗1针组、2针组血凝抑制抗体效价均小于1∶40,中和抗体效价均小于1∶200;血凝素含量为30、40μg/ml的甲型H1N1流感病毒亚单位疫苗1针组、2针组的血凝抑制抗体效价均大于1∶40,中和抗体效价均大于1∶200;血凝素含量为30、40μg/ml的甲型H1N1流感病毒亚单位疫苗1针组和2针组的血凝抑制抗体和中和抗体效价比较,差异均无统计学意义。结论:血凝素含量为30μg/ml的甲型H1N1流感病毒亚单位疫苗接种1针即可达到理想的免疫效果。 Objective: To observe the immunogenicity of domestic H1N1 influenza subunit vaccine in mice. Methods: The H1 N1 influenza subunit vaccines with various hemagglutinin contents (20, 30, 40μg/ml), three batches for each, were used for im- munization of mice. Mice were divided various groups, 10 for each, and were injected ip. with 1 and 2 doses of influenza subunit vac- cines with various hemagglutinin contents respectively ,0.5 ml for each, using those unimmunized as a control group. The interval be- tween doses was one week. Serum samples were collected 21 d after the first dose and determined for hemagglutination inhibition (HI) and neutralizing antibody titers. Results: The HI and neutralizing antibody titers of mice immunized with 1 and 2 doses of H1N1 influ- enza subunit vaccine (hemagglutinin contents of 20μg/ml) were less than 1:40 and 1:200 respectively. However,the HI antibody ti- ters of mice immunized with ! and 2 doses of H1N1 influenza subunit vaccine (hemagglutinin contents of 30, 40μg/ml) were more than 1 : 40, and nuetralizing antibody titers were more than 1 : 200. Neither HI nor neutralizing antibody titers showed significant differ- ence in the mice immunized with 1 and 2 doses of H1N1 influenza subunit vaccine (hemagglutinin contents of 30, 40μ g/ml). Con- clusion: The immune effects of one dose of H1N1 influenza subunit vaccine with hemagglutinin contents of 30μg/ml are satisfactory.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2013年第6期615-617,共3页 Chinese Journal of Immunology
基金 长春市社会发展科技计划资助项目(10SF03)
关键词 流感病毒亚单位疫苗 血凝素 小鼠 免疫原性 H1N1 Influenza subunit vaccine Hemagglutinin Mice Immunogenicity
  • 相关文献

参考文献10

  • 1Palese P. Influenza: old and new threats[ J]. Nat Med, 2004 ; 10( 12 Suppl) : S82-87. 被引量:1
  • 2World Health Organization. Seasonal influenza[ OL]. http://www. who. int/mediacentre/factsheets/fs211/en/index, html, 2011(03) ; 17. 被引量:1
  • 3徐伟,翟力军,崔德军,王涛,华伟玉,王青海,李洪军,李彦丽,李馥程,张丽杰,孙美平.医务人员计划接种季节性和甲型H1N1流感疫苗情况调查[J].中华流行病学杂志,2010,31(6):714-715. 被引量:15
  • 4Gerdil C. The annual production cycle for influenza vaccine [ J ]. Vaccine, 2003 ; 21 (16) : 1776-1779. 被引量:1
  • 5董蒲梅,李玉秦,郑天柱,贾永普,李锋,韩同武,乔荣宪,张保华.流行性感冒灭活亚单位疫苗和裂解疫苗的安全性和免疫原性的比较研究[J].中华流行病学杂志,2003,24(7):570-573. 被引量:20
  • 6Taubeuberger J K, Morens D M, Influenza: the once and future pan- demic[J]. Public Health Rep, 2010; 125(Suppl 3) : 16-26. 被引量:1
  • 7Wang C C, Chen J R, Tseng Y C et al. Glycans on influenza hemag- glutinin affect receptor binding and immune response [ J ]. Proc Natl Acad Sci USA, 2009; 106(43) : 18137-18142. 被引量:1
  • 8Van Damme P, Arnou R, Kafeja F et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques : a randomised comparative study [J]. BMC In- fect Dis, 2010; 10: 134. 被引量:1
  • 9Gildea S, Arkins S, Walsb C et al. A comparison of antibody respon- ses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses-a randomised blind study [ J ]. Vaccine, 2011; 29(22): 3917-3922. 被引量:1
  • 10邵惠训.流感疫苗的现状与未来[J].国际病毒学杂志,2010,17(4):110-115. 被引量:17

二级参考文献15

  • 1Ahmed AH, Nicholson KG. Nguyen-van T, et al. Effectiveness of influenza vaccination in reducing hospital admissions during the epidemic of 1989-1990. Epidemical Infect, 1997,1 : 27-33. 被引量:1
  • 2Xie H,Liu TM.A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses,including highly pathogenic A/Vienam/1203/2004,in mice[J].J Infect Dis,2009,200(12):1874-1883. 被引量:1
  • 3Beigel JH,Voell J et al.Safety and immunogenicity of multiple and higher doses of an inactivated influenza A /H5N1 vaccine[J].J Infect Dis,2009,200(4):501-509. 被引量:1
  • 4Beran J,Veronika Tet al.Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults:A prospective,randomized,placebo-controlled trial[J].J Infect Dis,2009,200(12):1861-1869. 被引量:1
  • 5Kristin LN,Nichol MD et al.Effectiveness of influenza vaccine in the community-Dwelling elderly[J].New Engl J Med,2007,357:1373-1381. 被引量:1
  • 6Stowe J,Andrews N et al.Investigation of the temporal association of Gaillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom general practice research data base[J].Am J Epidem,2009,169(3):382-388. 被引量:1
  • 7Reisinger KS,Block SL et al.Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs:comparison of safety reactogenicity,and immunogenicity[J].J Infect Dis,2009,200(6):849-857. 被引量:1
  • 8Belshe RB,Edwards KM et al.Live attenuated versus inactivated influenza vaccine in infants and young children[J].N Engl J Med,2007,356:685-696. 被引量:1
  • 9Szymczakiewicz-Multanowska A,Groth N et al.Safety and immunogenicity of a novel influenza subunit vaccine produced in mammalian cell culture[J].J Infect Dis,2009,200(6):841-848. 被引量:1
  • 10Strauss JH,Strauss FG.Viruses and human disease[B].2ed.167,Elsevier,2008. 被引量:1

共引文献48

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部